Study finds bebtelovimab therapy lacks efficacy in patients infected with SARS-CoV-2 Omicron subvariants


Researchers assessed the impact of bebtelovimab (BEB) monoclonal antibody in the treatment of high-risk SARS-CoV-2 Omicron variant-infected patients.

Where do women filmmakers stand in India’s major film festival?

Previous article

Researchers achieve contactless electrocardiogram monitoring

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News